1. Home
  2. KRT vs CGEM Comparison

KRT vs CGEM Comparison

Compare KRT & CGEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Karat Packaging Inc.

KRT

Karat Packaging Inc.

N/A

Current Price

$52.63

Market Cap

1.1B

Sector

Industrials

ML Signal

N/A

Logo Cullinan Oncology Inc.

CGEM

Cullinan Oncology Inc.

N/A

Current Price

$15.66

Market Cap

999.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KRT
CGEM
Founded
2000
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Plastic Products
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
999.4M
IPO Year
2019
2020

Fundamental Metrics

Financial Performance
Metric
KRT
CGEM
Price
$52.63
$15.66
Analyst Decision
Buy
Strong Buy
Analyst Count
3
12
Target Price
★ $46.50
$34.60
AVG Volume (30 Days)
133.5K
★ 712.5K
Earning Date
11-05-2026
11-17-2026
Dividend Yield
★ 3.54%
N/A
EPS Growth
★ 4.70
N/A
EPS
★ 1.80
N/A
Revenue
★ $467,743,000.00
N/A
Revenue This Year
$12.22
N/A
Revenue Next Year
$8.47
$300.03
P/E Ratio
$29.72
★ N/A
Revenue Growth
★ 10.67
N/A
52 Week Low
$20.61
$6.73
52 Week High
$56.06
$23.19

Technical Indicators

Market Signals
Indicator
KRT
CGEM
Relative Strength Index (RSI) 49.90 49.86
Support Level $52.21 $12.73
Resistance Level $55.36 $16.31
Average True Range (ATR) 1.46 0.87
MACD -0.29 0.30
Stochastic Oscillator 17.95 82.28

Price Performance

Historical Comparison
KRT
CGEM

About KRT Karat Packaging Inc.

Karat Packaging Inc is a distributor and manufacturer of disposable foodservice products and related items, including containers, bags, tableware, cups, lids, cutlery, straws, specialty beverage ingredients, gloves, and janitorial supplies, available in plastic, paper, biopolymer-based, and other compostable forms. The Company focuses on environmentally friendly products and provides customized solutions including product development, design, printing, and logistics services. It serves customers through chains and distributors, retail, and e-commerce/online, and operates in the manufacturing and distribution of single-use food and beverage products, as well as specialty food and beverage products and restaurant and warehouse supplies.

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a clinical-stage biopharmaceutical company developing therapies for autoimmune diseases and cancer. Its development pipeline comprises the following drug candidates: CLN-978, a CD19xCD3 bispecific T cell engager that is being developed for autoimmune diseases; CLN-049, a FLT3xCD3 bispecific T cell engager being evaluated in an ongoing clinical trial in patients with relapsed/refractory acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS); Velinotamig, a BCMAxCD3 bispecific T cell engager being developed to counter autoimmune diseases; and Zipalertinib, being developed as a treatment for non-small cell lung cancer. Additionally, the company is developing several preclinical programs in autoimmune diseases and oncology.

Share on Social Networks: